**Dear editor,**

We read the recent published paper by Chen and colleagues in journal of Infection with great interest, which described the clinical progression of patients with COVID-19 in Shanghai, China.[@bib0001] Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan, China and spread globally to become a public health emergency of international concern.[@bib0002] Patients with COVID-19 tend to progress after onset of symptoms within 7 days[@bib0001] and severe type may rapidly progress to acute respiratory distress syndrome (ARDS) or end-organ failure.[@bib0003] ^,^ [@bib0004] Therefore, early and simple identification of patients who require intensive respiratory or vasopressor support (IRVS) would be of considerable value during the outbreak of the COVID-19 crisis. Thus far, there are no effective severity assessment tools for patients with COVID-19.

Here, we performed a retrospective single-center study to compare the performance of simple score systems such as quick sepsis-related organ failure assessment (qSOFA), the CURB-65 score adopted by the British Thoracic Society, and its simpler versions (CRB and CRB-65) to predict the need for IRVS in patients with COVID-2019. Patients with confirmed COVID-19 and age ≥18 years hospitalized between February 7, 2020 and February 17, 2020 in Renmin Hospital of Wuhan University were screened in this study. Patients were excluded if they died within 48 h of admission, were pregnant, or had a Do Not Resuscitate (DNR) order. Baseline demographics, co-morbidities, clinical symptoms or signs, vital signs, laboratory results on admission, and outcomes were collected. The CRB, CRB-65, CURB-65 and qSOFA scores were calculated on basis of demographic and clinical characteristics of each patient.

A total of 116 patients were eventually included for this study. The baseline characteristics are presented in [Table 1](#tbl0001){ref-type="table"} . The median age of this cohort was 63\[IQR 51 to 72\] and 47.4% patients were males. The most common symptom was fever (86.2%), followed by fatigue (85.3%) and cough (69.0%). On admission, the median scores of CRB, CRB-65, CURB-65, and qSOFA were 0\[0,1\], \[0,1\], 1\[0,2\] and 1\[0,1\], respectively. A total of 25 (21.6%) patients needed IRVS during the period of hospital stay. Patients with IRVS had higher CRB (1\[0,2\] vs. 0\[0,0\], *P*\<0.001), CRB-65 (2\[1,3\] vs. 1\[0,1\], *P*\<0.001), CURB-65 (3\[2,3\] vs. 1\[0,1\], *P*\<0.001), and qSOFA scores (1\[1,2\] vs. 1\[0,1\], *P*=0.001) than non-IRVS patients. The hospital mortality rate in this cohort was 7.8%. The median length of hospital stay was 29 \[18,36\] days.Table 1Clinical characteristics of COVID-19 patients.Table 1Entire cohortNo need for IRVSNeed for IRVS*P* valueNumber of patients1169125Age (years)63\[51, 72\]61\[48,69\]72\[63,81\]\<0.001Gender (male), n (%)55(47.4)42(46.2)13(52)0.66Smoking history, n (%)10(8.6)9(9.9)1(4)0.69ComorbiditiesHypertension, n (%)38(32.8)25(27.5)13(52)0.03Diabetes mellitus, n (%)20(17.2)15(16.5)5(20)0.77CAD, n (%)12(10.3)9(9.9)3(12)0.72COPD, n (%)2(1.7)0(0)2(8)0.05Cerebrovascular disease, n (%)2(1.7)1(1.1)1(4)0.39Chronic renal disease, n (%)4(3.4)3(3.3)1(4)1.00Signs and symptomsFever, n (%)100(86.2)76(83.6)24(96)0.19Cough, n (%)80(69.0)62(68.1)18(72)0.81Sputum production, n (%)15(12.9)11(12.1)4(16)0.74Fatigue, n (%)99(85.3)76(83.5)23(92)0.36Headache, n (%)6(5.2)6(6.6)0(0)0.34Dyspnea, n (%)66(56.9)44(48.4)22(88)\<0.001Nausea or vomiting, n (%)25(21.6)18(19.8)7(28)0.41Diarrhea, n (%)23(19.8)18(19.8)5(20)1.00Anorexia, n (%)8(6.9)2(2.2)6(24)0.001Myalgia or arthralgia, n (%)10(8.6)8(8.8)2(8)1.00Onset of symptom to hospital admission12\[9,16\]12\[9,17\]10\[7,16\]0.08Vital signs at hospital admissionAltered mental status, n (%)6(5.2)0(0)6(24)\<0.001Heart rate, beats/minute90\[79, 102\]86\[78,100\]96\[86,107\]0.02Respiratory rate, breaths/minute23\[20,29\]22\[20,25\]32\[22,35\]\<0.001Systolic blood pressure, mm Hg132\[122,145\]131\[122, 144\]137\[121,152\]0.38Diastolic blood pressure, mm Hg78\[68,84\]79\[69,84\]74\[66,91\]0.98Severity of illness scores at hospital admissionCRB0\[0,1\]0\[0,0\]1\[0,2\]\<0.001CRB-651\[0,1\]1\[0,1\]2\[1,3\]\<0.001CURB-651\[0,2\]1\[0,1\]3\[2,3\]\<0.001qSOFA1\[0,1\]1\[0,1\]1\[1,2\]0.001Blood urea nitrogen, mmol/L4.85\[3.91, 6.30\]4.67\[3.69,5.84\]7.35\[4.85,9.28\]\<0.001Respiratory supportHigh flow nasal cannula, n (%)24(20.7)0(0)24(96)\<0.001Non-invasive mechanical ventilation, n (%)5(4.3)0(0)5(20)\<0.001Invasive mechanical ventilation, n (%)8(6.9)0(0)8(32)\<0.001Renal replacement therapy, n (%)3(2.6)2(2.2)1(4)0.52Extracorporeal membrane oxygenation, n (%)1(0.9)0(0)1(4)0.22Need for vasopressor support, n (%)9(7.8)0(0)9(36)\<0.001Need for IRVS, n (%)25(21.6)0(0)25(100)\<0.001Hospital mortality, n (%)9(7.8)0(0)9(36)\<0.001Hospital length of stay, days29\[18,36\]28\[18,33\]38\[8,49\]0.18[^2][^3]

ROC curve analyses were performed to evaluate the performance of four simple score systems to predict the need for IRVS. The AUC, optimal cut-off value, sensitivity, specificity, and positive and negative predictive values of each score system were shown in [Table 2](#tbl0002){ref-type="table"} . The optimal cut-off score of CRB-65 for prediction of IRVS was 2, which provided sensitivity of 64% and specificity of 93.4%. The AUC values of the CRB-65 score in predicting the need for IRVS were much higher than those for the qSOFA score (0.81 ± 0.05 vs. 0.70 ± 0.06, *P*=0.02). The CRB-65 had higher AUC values than CRB score for IRVS prediction, however, the difference was not statistically significant (0.81 ± 0.05 vs. 0.77 ± 0.05, *P*=0.22). The AUC values were comparable between CRB-65 and CURB-65 for IRVS prediction (0.81 ± 0.05 vs. 0.85 ± 0.05, *P*=0.08).Table 2Performance of variables in predicting clinical outcomes.Table 2OutcomesPredictorsAU ROC95% CIPCut-offSensitivity (%)Specificity (%)PPVNPVLR+LR-Need for IRVS**CRB0.77 ± 0.050.69-0.85\<0.00117279.148.691.13.450.35**CRB22896.770838.490.74CRB-650.81 ± 0.050.73-0.88\<0.00118845.130.693.21.60.27**CRB-6526493.472.790.49.710.39**CRB-6532497.87582.410.920.78CURB-650.85 ± 0.050.77-0.91\<0.00118842.929.792.91.540.28**CURB-6528087.964.594.16.620.23**CURB-6535296.781.28815.770.5CURB-6541298.97580.410.920.89**qSOFA0.70 ± 0.060.60-0.78\<0.00118047.329.489.61.520.42**qSOFA22498.985.782.621.840.77[^4][^5][^6]

To the best of our knowledge, the present study is the first to investigate the predictive performance of simple score systems in patients with COVID-19. In this study, the CRB-65 score could better identify patients with COVID-19 at risk for IRVS than the qSOFA score. The CRB score contains the same three clinical parameters used in qSOFA score (confusion, respiratory rate, and blood pressure). However, the thresholds for tachypnea and hypotension in CRB were stricter than the qSOFA score (respiratory rate ≥ 30/min in CRB vs. ≥ 22/min in qSOFA; blood pressure: systolic blood pressure ≤ 100 mmHg in qSOFA vs. \< 90 mmHg~sys~ or ≤ 60 mmHg~dias~ in CRB). It seems that qSOFA is more accurate than the CRB score for predicting IRVS. However, in this study, the AUC values of CRB and qSOFA scores were comparable without statistically significant differences. After including the parameter of age, the CRB-65 score performed better than the qSOFA score in predicting requirement of IRVS. As age ≥ 65 years was included in the CRB-65 score, it provided additional predictive performance compared with the CRB score. This result was supported by previous reports, which showed that age was an independent risk factor for mortality in patients with COVID-19.[@bib0005] ^,^ [@bib0006]

The CRB-65 score has been reported to have a similar predictive performance to that of the CURB-65 and PSI scores in predicting the severity of CAP.[@bib0007], [@bib0008], [@bib0009] In our study, the CRB-65 and CURB-65 scores also had a similar prognostic value in predicting the receipt of IRVS. The CRB-65 score makes it easy to assess the severity of COVID-19 without the limit of laboratory data for blood urea nitrogen especially in the pandemic of COVID-19, thereby allowing earlier triage decisions.

In conclusion, the CRB-65 score could better identify patients with COVID-19 at risk for IRVS than the qSOFA score. The CRB-65 may be a useful score tool for COVID-19 because of its simplicity in application especially in emergent and complicated conditions.
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